BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 29867772)

  • 21. [Disodium pamidronate (APD) in therapy of hypercalcemia in primary hyperparathyroidism].
    Kotzmann H; Svoboda T; Bernecker P; Clodi M; Woloszczuk W; Niederle B; Waldhäusl W; Luger A
    Wien Klin Wochenschr; 1994; 106(13):422-5. PubMed ID: 8091766
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electrolyte disturbances and cardiac arrhythmias in a dog following pamidronate, calcitonin, and furosemide administration for hypercalcemia of malignancy.
    Kadar E; Rush JE; Wetmore L; Chan DL
    J Am Anim Hosp Assoc; 2004; 40(1):75-81. PubMed ID: 14736909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Biochemical effects from treatment with bisphosphonate and surgery in patients with primary hyperparathyroidism.
    Jansson S; Morgan E
    World J Surg; 2004 Dec; 28(12):1293-7. PubMed ID: 15517486
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pamidronate treatment for hypercalcemia in an infant receiving parenteral nutrition.
    Bryowsky JJ; Bugnitz MC; Hak EB
    Pharmacotherapy; 2004 Jul; 24(7):939-44. PubMed ID: 15303458
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypercalcemia of malignancy in the palliative care patient: a treatment strategy.
    Kovacs CS; MacDonald SM; Chik CL; Bruera E
    J Pain Symptom Manage; 1995 Apr; 10(3):224-32. PubMed ID: 7543127
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Calcium-free hemodialysis for hypercalcemia of malignancy in a newborn.
    Pradhan M; Leonard MB
    Pediatr Nephrol; 2003 May; 18(5):474-6. PubMed ID: 12687453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hypercalcemia associated with tertiary hyperparathyroidism managed conservatively with pamidronate in a hemodialysis patient.
    Czosnowski LM; Hudson JQ; Canada RB
    Am J Med Sci; 2009 Apr; 337(4):300-1. PubMed ID: 19365180
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The rapid correction of hypercalcemia at presentation of acute lymphoblastic leukemia using high-dose methylprednisolone.
    Unal S; Durmaz E; Erkoçoğlu M; Bayrakçi B; Bircan O; Alikaşifoğlu A; Cetin M
    Turk J Pediatr; 2008; 50(2):171-5. PubMed ID: 18664083
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of pamidronate in a rat hypercalcemia model induced by cholecalciferol.
    Okada M; Noguchi S; Hasegawa Y; Inukai T
    Arzneimittelforschung; 1992 Apr; 42(4):543-6. PubMed ID: 1322674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of resistant hypercalcemia of malignancy with a proposed treatment algorithm.
    McMahan J; Linneman T
    Ann Pharmacother; 2009 Sep; 43(9):1532-8. PubMed ID: 19622757
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Malignant hypercalcemia in pregnancy: effect of pamidronate on uterine contractions.
    Culbert EC; Schfirin BS
    Obstet Gynecol; 2006 Sep; 108(3 Pt 2):789-91. PubMed ID: 17018504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oral prednisolone for management of persistent hypercalcemia afterhypercalcemic crisis in the Williams-Beuren syndrome.
    Varma TH; Sahitya DSK; Dusad S; Agarwal A; Dayal D
    Pediatr Endocrinol Diabetes Metab; 2018; 24(2):106-109. PubMed ID: 30300432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of pamidronate and interferon-alpha on bone and lung metastases and hypercalcemia in a patient with renal cell carcinoma].
    Kise H; Kobayashi K; Arima K; Yanagawa M; Tochigi H; Kawamura J; Hioki T; Sugiura Y
    Hinyokika Kiyo; 1996 Nov; 42(11):879-81. PubMed ID: 8973939
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pamidronate in a girl with chronic renal insufficiency dependent on parenteral nutrition.
    Duke JL; Jones DP; Frizzell NK; Chesney RW; Hak EB
    Pediatr Nephrol; 2003 Jul; 18(7):714-7. PubMed ID: 12750976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin D intoxication and hypercalcaemia in an infant treated with pamidronate infusions.
    Ezgu FS; Buyan N; Gündüz M; Tümer L; Okur I; Hasanoglu A
    Eur J Pediatr; 2004 Mar; 163(3):163-5. PubMed ID: 14714183
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous aminohydroxypropylidene bisphosphonate does not modify 99mTc-hydroxymethylene bisphosphonate bone scintigraphy. A prospective study.
    Macro M; Bouvard G; Le Gangneux E; Colin T; Loyau G
    Rev Rhum Engl Ed; 1995 Feb; 62(2):99-104. PubMed ID: 7600079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Idiopathic infantile hypercalcaemia in 5-month old girl.
    Gut J; Kutílek Š
    Prague Med Rep; 2011; 112(2):124-31. PubMed ID: 21699761
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis of a case with Williams-Beuren syndrome with nephrocalcinosis using chromosome microarray analysis].
    Jin SJ; Liu M; Long WJ; Luo XP
    Zhonghua Er Ke Za Zhi; 2016 Dec; 54(12):941-945. PubMed ID: 27938597
    [No Abstract]   [Full Text] [Related]  

  • 39. Pamidronate for long-term control of hypercalcemia associated with Williams syndrome.
    Ismail J
    Indian Pediatr; 2015 Feb; 52(2):163-4. PubMed ID: 25691196
    [No Abstract]   [Full Text] [Related]  

  • 40. Combination of calcitonin and pamidronate for emergency treatment of malignant hypercalcemia.
    Sekine M; Takami H
    Oncol Rep; 1998; 5(1):197-9. PubMed ID: 9458321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.